The Coming Disruptive Digital Transformation of Pharma Marketing
Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities.
Silja Chouquet: “DE-scribe” Medicines to Improve Adherence
In this 5-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies apply resources and their brains to come up with a solution that helps people take their medication and use these insights to develop the next generation of treatments.
Doris Peter of Consumer Reports Speaks Out Against Off-Label Promotion of Drugs by Pharma
This 3.5-minute audio snippet was taken from the statements made by Dr. Doris Peter, Principal Investigator, Best Buy Drugs Project at Consumer Reports, at a November 9, 2016, FDA public hearing on off-label drug promotion by the pharmaceutical industry.
Butler: Role of Social Media in Putting Patients First & Foremost in the Minds...
In this 1.5-minute audio snippet, Alex Butler, Managing Director at The Earthworks and recipient of the first Pharmaguy™ Pioneer Award, posits that social media has been instrumental in putting the patient first & foremost in the minds of pharma marketers.
Brian Fox: The Digital Gap Between Pharma and Other Industries
In this 2-minute audio snippet, Brain Fox, Senior Partner at McKinsey, talks about how the pharma industry lags other industries in its investment in digital technology and in testing the effectiveness of its digital marketing campaigns.
Bradley Merrill Thompson: The Need for More Balanced Enforcement of Mobile Medical App Regulations
Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, describes a urine analysis mobile app that illustrates why the mobile health app industry needs more consistent and balanced FDA enforcement of mobile regulations.
Bill Evans and Zoe Dunn: Share Your Social Media & Mobile Success Stories So...
In this 3.5-minute audio snippet, Bill Evans, Executive Vice President and Chief Digital Officer for Team Chemistry @ WPP, and Zoe Dunn, Principal at Hale Advisors, Inc., talk about their disappointment with speakers at industry digital and social media conferences whose presentations lack depth and most important do not showcase their success stories so that attendees can actually learn something. It's not about revealing the
Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma
The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic action.
Barrette and Gratton: Importance of the Patient Voice in Market Research
In this 2.5-minute audio snippet, Jack Barrette and Fabio Gratton, talk about Truvio and the importance of the patient voice in market research and how to distill the sentiment from patient conversations.
Patricia Alves and Jaclyn Fonteyne: TweetChat Return on Investment
In this 2.5-minute audio snippet, Patricia Alves and Jaclyn Fonteyne, members of the Boehringer Ingelheim Social Media Team, talk about the working with legal-regulatory to plan TweetChats and what they consider to be the measures of success -- aka, return on investment -- for pharma TweetChats.









